Deze website maakt gebruik van functionele cookies waaronder analytische cookies.
De hiermee verkregen statistische gegevens zijn door ons niet herleidbaar naar individuele gebruikers.
Aanvullend kunt u marketing cookies accepteren of weigeren.
Weigert u deze aanvullende cookies of maakt u geen keuze, dan worden alleen functionele cookies geplaatst.
Zie voor meer informatie onze cookie policy.
Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.